Dominican Republic vs Suriname: Share of pregnant women with HIV that receive antiretroviral therapy
Dominican Republic
68.0%
in 2024
Suriname
66.0%
in 2024
Dominican Republic rank
54th
Suriname rank
56th
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Dominican Republic
- Suriname
How they compare
Dominican Republic currently reports 68.0% against 66.0% in Suriname, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Suriname ahead.
Dominican Republic ranks 54th and Suriname ranks 56th of 84 countries.
Suriname has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Dominican Republic | Suriname | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.8% | 28.2% | 11.4% | Suriname |
| 2010s | 37.7% | 72.5% | 34.8% | Suriname |
| 2020s | 49.8% | 68.2% | 18.4% | Suriname |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Dominican Republic or Suriname?
- Dominican Republic, at 68.0% against 66.0% in Suriname as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Dominican Republic and Suriname?
- 2.0%, with Dominican Republic ahead.
- How many years of comparable data are there for Dominican Republic and Suriname?
- 25 years are reported by both, from 2000 to 2024.
- How do Dominican Republic and Suriname rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Dominican Republic ranks 54th and Suriname ranks 56th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.